Diagnostic assay and method of treatment for miscarriage...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007900, C435S007920, C514S009800

Reexamination Certificate

active

07968303

ABSTRACT:
Methods for diagnosing risk of miscarriage and/or premature birth, foetal abnormalities, cancer (e.g. prostate cancer) and inflammatory disease (e.g. rheumatoid arthritis) are disclosed which involve determining abnormal levels of macrophage inhibitory cytokine-1 (MIC-1) in a body sample or, otherwise, determining the presence of a MIC-1 variant protein. Also disclosed are methods for reducing the risk of miscarriage and/or premature birth in pregnant subjects, and methods for treatment of inflammatory disease and/or cancer.

REFERENCES:
patent: 5994102 (1999-11-01), Hudson et al.
patent: 6051424 (2000-04-01), Kato et al.
patent: 6180602 (2001-01-01), Kato et al.
patent: 6420543 (2002-07-01), Lee et al.
patent: 6465181 (2002-10-01), Billing-Medel et al.
patent: 6500638 (2002-12-01), Hudson et al.
patent: 6521227 (2003-02-01), Hudson et al.
patent: 2003/0059431 (2003-03-01), Hudson et al.
patent: 250688 (1995-10-01), None
patent: 258293 (1995-10-01), None
patent: WO 96/18730 (1996-06-01), None
patent: WO 97/00958 (1997-01-01), None
patent: WO 99/06445 (1999-02-01), None
patent: WO 99/21011 (1999-04-01), None
patent: WO 00/70051 (2000-11-01), None
Alberts et al; “Molecular Biology of the Cell”, 3rdedition,Garland Publishing Inc.; pp. 1255-1272 (1994).
Li, et al;J. Biol. Chem.; vol. 275; pp. 20127-20135 (2000).
Fairlie et al;Biochemistry, vol. 40; pp. 65-73 (2001).
Harlow et al; “Antibodies, A Laboratory Manual”;Cold Spring Harbor Laboratory; p. 76 (1988).
Kuby, “J. Immunology”;W.H. Freeman and Company; p. 125 (1992).
Whisstock et al; “Prediction of protein function from protein sequence and structure”;Quarterly Reviews of Biophysics; vol. 36; pp. 307-340 (2003).
Fairlie et al; “The propeptide of the transforming growth factor beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion”;J. Biol. Chem.; vol. 276; pp. 16911-16918 (2001).
Yokoyama-Kobayashi, et al; “Human cDNA Encoding a Novel TGF-β Superfamily Protein Highly Expressed in Placenta”; J. Biochem., vol. 122, 622-626, (1997).
Lawton, et al; “Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta”; Gene, vol. 203, 17-26; (1997).
Hillier, et al; “The Relationship of Amniotic Fluid Cytokines and Preterm Delivery, Amniotic Fluid Infection, Histologic Chorioamnionitis, and Chorioamnion Infection”; Obstetrics & Gynacology, vol. 81, 941-948; (1993).
Hromas et al; “PLAB, a novel placental bone morphogenetic protein”; Biochimica et Biophysica Acta, vol. 1354, 40-44; (1997).
Paralkar et al; “Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family”; J. Biol. Chem., vol. 273, issue 22, 13760-13767; (1998).
Moore, et al; “The Transforming Growth Factor-β Superfamily Cytokine Macrophage Inhibitory Cytokine-1 Is Present in High Concentrations in the Serum of Pregnant Women”; The Journal of Clinical Endocrinology & Metabolism, vol. 85, No. 12, 4781-4788; (2000).
Fairlie, et al; “MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation”; Journal of Leukocyte Biology, vol. 65, 2-5; (1999).
Bootcov, et al; “MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily”; Proc. Nat'l. Acad. Sci USA, vol. 94, 11514-11519; (1997).
Strelau, et al; “GDF-15/MIC-1 a novel member of the TGF-β superfamily”; Journal of Neural Transmission; Supplementum 60; Advances in Research on Neurodegeneration vol. 8; 273-276; (2000).
Strelau, et al; “Growth/Differentiation Factor-15/Macrophage Inhibitory Cytokine-1 Is a Novel Trophic Factor for Midbrain Dopaminergic Neurons in Vivo”; The Journal of Neuroscience, vol. 20 (23), 8597-8603; (2000).
Bottner, et al; “Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1)”; Gene, vol. 237, 105-111; (1999).
Bottner, et al; “Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues”; Cell and Tissue Research, vol. 297, 103-111; (1999).
Bauskin, et al; “The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-β superfamily memer, acts as a quality control determinant for correctly folded MIC-1”; The EMBO Journal, vol. 19, No. 10, 2212-2220; (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic assay and method of treatment for miscarriage... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic assay and method of treatment for miscarriage..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic assay and method of treatment for miscarriage... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2622635

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.